Could a common arthritis drug ease long COVID brain fog?
Disease control
Recruiting now
This study tests whether baricitinib, an anti-inflammatory drug, can improve thinking, physical function, and quality of life in people with long COVID. About 550 adults who had COVID-19 at least 6 months ago will receive either baricitinib or a placebo for 6 months. The main goa…
Phase: PHASE3 • Sponsor: Wes Ely • Aim: Disease control
Last updated May 11, 2026 20:38 UTC